TADA Antikörper und Ähnliche Produkte
Santa Cruz Biotechnology bietet eine Vielzahl von TADA-Antikörpern zur Untersuchung des TADA-Proteins (TGF-beta-aktivierte Kinase 1/MAP3K7) an. Monoklonale TADA-Antikörper sind für verschiedene Forschungsanwendungen validiert, darunter Western Blotting (WB), Immunpräzipitation (IP), Immunfluoreszenz (IF), Immunhistochemie mit Paraffin eingebetteten Schnitten (IHCP), Durchflusszytometrie (FCM) und Enzyme-Linked Immunosorbent Assay (ELISA). TADA spielt eine entscheidende Rolle in zellulären Signalwegen, insbesondere bei der Regulierung von Entzündung und Apoptose. Die Beteiligung von TADA am TGF-beta-Signalweg unterstreicht seine Bedeutung für verschiedene physiologische Prozesse und Krankheitszustände, einschließlich Krebs und Fibrose. Das Verständnis der Funktion von TADA ist für die Aufklärung seiner Rolle bei wichtigen biologischen Prozessen unerlässlich. Forscher auf der ganzen Welt verlassen sich auf monoklonale TADA-Antikörper, um ihre Studien über Zellsignale und Krankheitsmechanismen voranzutreiben. Monoklonale TADA-Antikörper ermöglichen die präzise Erkennung und Analyse zellulärer Signalwege. Die monoklonalen TADA-Antikörper von Santa Cruz Biotechnology unterstützen Forscher dabei, wichtige Beiträge zum wissenschaftlichen Verständnis der Zellregulation und des Krankheitsverlaufs zu leisten.
Siehe auch...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
TADA Antikörper
| Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|---|
TADA2B Antikörper (MB-56) | sc-130479 | mouse IgG2a κ | 2-111 (h) | WB, IP | h | 1 | ||
TADA3L Antikörper (D-10) | sc-166118 | mouse IgG1 κ | 1-286 (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
TADA3L Antikörper (H-1) | sc-166119 | mouse IgG2a κ | 1-286 (h) | WB, IP, IF, ELISA | m, r, h | neu |
TADA CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TADA2B CRISPR/Cas9 KO Plasmid (h) | sc-406224 | h | Gene Knockout | GFP | 0 | ||
TADA2B CRISPR/Cas9 KO Plasmid (h2) | sc-406224-KO-2 | h | Gene Knockout | GFP | 0 | ||
TADA2B HDR Plasmid (h2) | sc-406224-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
TADA2B Double Nickase Plasmid (h) | sc-406224-NIC | h | Gene Knockout | Puromycin | 0 | ||
TADA2B Double Nickase Plasmid (h2) | sc-406224-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TADA2L CRISPR/Cas9 KO Plasmid (h) | sc-409144 | h | Gene Knockout | GFP | 0 | ||
TADA2L HDR Plasmid (h) | sc-409144-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TADA2L Double Nickase Plasmid (h) | sc-409144-NIC | h | Gene Knockout | Puromycin | 0 | ||
TADA2L Double Nickase Plasmid (h2) | sc-409144-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TADA2L CRISPR/Cas9 KO Plasmid (m) | sc-432159 | m | Gene Knockout | GFP | 0 | ||
TADA2L HDR Plasmid (m) | sc-432159-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TADA2L Double Nickase Plasmid (m) | sc-432159-NIC | m | Gene Knockout | Puromycin | 0 | ||
TADA2L Double Nickase Plasmid (m2) | sc-432159-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
TADA3L CRISPR/Cas9 KO Plasmid (h) | sc-409222 | h | Gene Knockout | GFP | 0 | ||
TADA3L HDR Plasmid (h) | sc-409222-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
TADA3L Double Nickase Plasmid (h) | sc-409222-NIC | h | Gene Knockout | Puromycin | 0 | ||
TADA3L Double Nickase Plasmid (h2) | sc-409222-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
TADA3L CRISPR/Cas9 KO Plasmid (m) | sc-430363 | m | Gene Knockout | GFP | 0 | ||
TADA3L HDR Plasmid (m) | sc-430363-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
TADA3L Double Nickase Plasmid (m) | sc-430363-NIC | m | Gene Knockout | Puromycin | 0 | ||
TADA3L Double Nickase Plasmid (m2) | sc-430363-NIC-2 | m | Gene Knockout | Puromycin | 0 |
TADA CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TADA2B CRISPR Activation Plasmid (h) | sc-406224-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2B CRISPR Activation Plasmid (h2) | sc-406224-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2B Lentiviral Activation Particles (h) | sc-406224-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2B Lentiviral Activation Particles (h2) | sc-406224-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L CRISPR Activation Plasmid (h) | sc-409144-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L CRISPR Activation Plasmid (h2) | sc-409144-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L Lentiviral Activation Particles (h) | sc-409144-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L Lentiviral Activation Particles (h2) | sc-409144-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L CRISPR Activation Plasmid (m) | sc-432159-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L CRISPR Activation Plasmid (m2) | sc-432159-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L Lentiviral Activation Particles (m) | sc-432159-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA2L Lentiviral Activation Particles (m2) | sc-432159-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L CRISPR Activation Plasmid (h) | sc-409222-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L CRISPR Activation Plasmid (h2) | sc-409222-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L Lentiviral Activation Particles (h) | sc-409222-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L Lentiviral Activation Particles (h2) | sc-409222-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L CRISPR Activation Plasmid (m) | sc-430363-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L CRISPR Activation Plasmid (m2) | sc-430363-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L Lentiviral Activation Particles (m) | sc-430363-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
TADA3L Lentiviral Activation Particles (m2) | sc-430363-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |
TADA siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
TADA2B siRNA (h) | sc-156169 | h | Gene Silencing | N/A | 0 | ||
TADA2L siRNA (h) | sc-93756 | h | Gene Silencing | N/A | 0 | ||
TADA2L shRNA Plasmid (h) | sc-93756-SH | h | Gene Silencing | Puromycin | 0 | ||
TADA2L shRNA (h) Lentivirale Partikel | sc-93756-V | h | Gene Silencing | Puromycin | 0 | ||
TADA2L siRNA (m) | sc-154043 | m | Gene Silencing | N/A | 0 | ||
TADA2L shRNA Plasmid (m) | sc-154043-SH | m | Gene Silencing | Puromycin | 0 | ||
TADA2L shRNA (m) Lentivirale Partikel | sc-154043-V | m | Gene Silencing | Puromycin | 0 | ||
TADA3L siRNA (h) | sc-78466 | h | Gene Silencing | N/A | 3 | ||
TADA3L shRNA Plasmid (h) | sc-78466-SH | h | Gene Silencing | Puromycin | 3 | ||
TADA3L shRNA (h) Lentivirale Partikel | sc-78466-V | h | Gene Silencing | Puromycin | 3 | ||
TADA3L siRNA (m) | sc-77411 | m | Gene Silencing | N/A | 0 | ||
TADA3L shRNA Plasmid (m) | sc-77411-SH | m | Gene Silencing | Puromycin | 0 | ||
TADA3L shRNA (m) Lentivirale Partikel | sc-77411-V | m | Gene Silencing | Puromycin | 0 |